28. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials

BACKGROUND: The recent Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo highlights the sustained threat of EVD morbidity and mortality where healthcare and vaccine delivery are challenging. ERVEBO®, a live recombinant vesicular stomatitis virus (VSV) vaccine containing the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Simon, Jakub, Kennedy, Stephen, Mahon, Barbara, Dubey, Sheri, Grant-Klein, Rebecca, Liu, Ken, Hartzel, Jonathan, Coller, Beth-Ann, Welebob, Carolee, Hanson, Mary, Grais, Rebecca
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Poster Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776050/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.073
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares